On June 11, 2025, CytomX Therapeutics, Inc. conducted its Annual Meeting, where stockholders approved significant amendments to the 2015 Equity Incentive Plan, increasing the total shares available for grant to 6,300,000 and adjusting other plan provisions. Additionally, the Employee Stock Purchase Plan was amended to remove its evergreen provision and extend its expiration indefinitely.